Skip to main content

Three Essential Ingredients Of Effective Trading Processes

As the quote from Peter Drucker suggests, efficiency is of limited value if we're not effective.  We not only need to do things right, but ensure that we're doing the right things.

What goes into successful trading processes?  Here are three hallmarks of effectiveness that I've observed across a variety of professional traders:

1)  Original Research - I recently spoke with a trader about the difference between trading ideas that you develop for yourself vs. ideas that you borrow from what your read or hear from others.  The successful traders I know do their own work.  Yes, they discuss ideas with people and, yes, they read research, but where they add value is in how they synthesize that information.  Without digging into ideas on your own, you never truly achieve a sense of discovery and conviction in those ideas.  As a result, it's easy to give up on the trades as soon as they encounter adverse price movement.  The best trading ideas are distinguished by their breadth (combining information across time frames and/or markets); depth (level of detail and understanding); and originality (looking at new things or viewing old things in new ways).  Successful generation of ideas goes beyond consensus thinking.

2)  Planful Expression and Management of Trades - The successful traders I know put considerable time into structuring their trades (finding very good risk/reward) and managing their positions (scaling in or out of trades, managing risk/reward in real time).  One trader recently wanted to benefit from an anticipated decline in stocks, but was concerned about sharp short-covering rallies.  He bought a long dated put spread and limited his dollar exposure to the trade.  That allowed him to ride out market choppiness and take a nice profit on the position when volatility expanded.  The thoughtful use of options enabled him to participate in a move that others missed because of getting stopped out due to market noise.  Yet another trader I know achieved a similar end by holding modestly sized core positions, trading with wider stops, and tactically taking profits when markets became stretched in a favorable direction.  Money management is central to the effectiveness of trading processes.

3)  Detailed Reviews - The best trading processes include an element of quality control.  By periodically reviewing performance and highlighting areas for improvement, traders ensure that they are learning and developing even as they may be drawing down.  As I've emphasized elsewhere, those detailed reviews also include episodes of very positive performance.  Traders who reverse engineer and map out their strengths are in a good position to turn best practices into process-driven habits.  Trading reviews provide the foundation of trading goals, and trading goals provide the template for future trading plans and actions.  Without reviews, goal setting, and further reviews, trading experience will not turn into trading expertise.  We learn, not from experience, but from what we do with our experience.

How effective is your trading?  What are you doing that is special and unique in each of these three areas?  If we don't do great things each day, our experience is unlikely to add up to anything great.

Further Reading:  Productivity and Success
.

Comments

Popular posts from this blog

Austerity-A Fancy Word for Destitute.

The reason for this post is not for the folks who have been caught in the first wave of personal economic hard reality, but the next wave. Regardless of the optimism espoused by grinning leaders and sycophant press, we are entering the final stage of global economic collapse. It began in 2008 and was forestalled for five years with fudge putty, but the weight of global indebtedness cannot be propped any longer and the final crunch is imminent. Austerity measures herald the final throes.  Indications of coming austerity.   Austerity measures are the final last ditch effort, futile or not! Back in the day many of us old-timers went through periods of "hard-times". In retrospect I realize there is no comparison to yesteryear hard times and today's version. Back then, expectations were never very high for the working class, there were no sophisticated systems or conveniences anyway. In fact the difference between being "set" or not was about having treats or not. Si...

Terrifying Arctic methane levels

A peak methane level of 3026 ppb was recorded by the MetOp-B satellite at 469 mb on December 11, 2021 am. This follows a peak methane level of  3644 ppb  recorded by the MetOp-B satellite at 367 mb on November 21, 2021, pm. A peak methane level of 2716 ppb was recorded by the MetOp-B satellite at 586 mb on December 11, 2021, pm, as above image shows. This image is possibly even more terrifying than the image at the top, as above image shows that at 586 mb, i.e. much closer to sea level, almost all methane shows up over sea, rather than over land, supporting the possibility of large methane eruptions from the seafloor, especially in the Arctic.  Also, the image was recorded later than the image at the top with the 3026 ppb peak, indicating that even more methane may be on the way. This appears to be confirmed by the Copernicus forecast for December 12, 2021, 03 UTC, as illustrated by the image below, which shows methane at 500 hPa (equivalent to 500 mb). Furthermore, ...

Women and children overboard

It's the  Catch-22  of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations,"  like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans."  Action began on that, too. There is still a long way to go. But this month there was a sign that ...